BTM-002
交联玻璃酸钠关节腔注射液 (江苏佳时泰医药生物科技)
Report date: 2026/01/26 16:40:59
NME
Base Information
Drug NameBTM-002
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Jiashitai Pharmaceutical Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesJiangsu Jiashitai Pharmaceutical Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A